Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: The TIBET registry
Heart and Vessels, Volume 27, No. 2, Year 2012
Notification
URL copied to clipboard!
Description
We sought to explore the immediate clinical and angiographic results of the Titan® stent implantation in diabetic patients, as well as the major adverse cardiac events (MACE) at 6-month follow-up. We enrolled 156 consecutive diabetic patients admitted to undergo percutaneous intervention for at least one significant (50%) coronary lesion. All lesions were treated with the Titan® stent implantation according to the contemporary interventional techniques. Patients were prospectively followed-up for at least 6 months. The primary endpoint was MACE at 6-month follow-up [cardiac death, myocardial infarction (MI), or target lesion revascularization (TLR)]. Secondary endpoints included angiographic and clinical procedural success, in-hospital MACE, TLR at 6-month follow-up, and stent thrombosis. The mean age was 66.7 ± 9.6 years, (68.4% males). A total of 197 Titan® stents were implanted in 163 lesions. Direct stenting was performed in 45.2% of the cases. The mean stent diameter was 3.1 ± 0.61 mm, and the mean length was 18.0 ± 8.9 mm. Average stent deployment pressure was 13.9 ± 4.2 bars. Angiographic procedural success was achieved in 154 (98.7%) cases, and clinical procedural success was achieved in 153 (98.1%) cases. One patient developed in-hospital non-Q-wave MI following the procedure. Clinical follow-up was completed in 155 (99.4%) patients. Three patients (1.9%) died of a cardiac or unknown cause, and two (1.3%) developed MI. TLR was performed in 11 patients (7.1%). Cumulative MACE at 6-month follow-up occurred in 16 (10.3%) patients. No patient suffered stent thrombosis. Titan® stent implantation in diabetic patients achieves an excellent immediate clinical and angiographic outcome, with a low incidence of MACE at mid-term follow-up. © 2011 Springer.
Authors & Co-Authors
Chavarri, Mariano Valdés
Spain, Murcia
Hospital Clínico Universitario Virgen de la Arrixaca
Bethencourt, Armando
Spain, Palma
Hospital Universitario Son Espases
Pinar, Eduardo
Spain, Murcia
Hospital Clínico Universitario Virgen de la Arrixaca
Gomez, Alfredo
Spain, Palma
Hospital Universitario Son Espases
Portales, Javier Fernández
Spain, Caceres
Hospital Virgen de Guadalupe de Cáceres
Pomar, Francisco
Spain, Valencia
Hospital General Universitario de Valencia
Calvo, Isabel
Spain, Zaragoza
Hospital Miguel Servet
Minguez, Jose Ramón López
Spain, Parla
Hospital Universitario Infanta Cristina
Valdesuso, Raúl
Spain, Albacete
Clinica Capio Recoletas
Moreu, José
Spain, Toledo
Complejo Hospitalario de Toledo
Martínez, Antonio
Spain, Castellon de la Plana
Hospital General de Castellon
Nammas, Wail M.
Egypt, Cairo
Faculty of Medicine - Ain Shams University
Statistics
Citations: 17
Authors: 12
Affiliations: 10
Identifiers
Doi:
10.1007/s00380-011-0136-2
ISSN:
09108327
e-ISSN:
16152573
Research Areas
Health System And Policy
Noncommunicable Diseases
Study Design
Randomised Control Trial
Cohort Study